Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
NY Valves 25: Early Outcomes of TAVI Valve with Intra-Annular Leaflet Position
Author(s): Santiago Garcia Added: 4 months ago
New York Valves 2025 -Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss outcomes from an observational study investigating early outcomes of the Navitor self-expandable transcatheter valve with intra-annular leaflet position. Approximately 3,000 patients with severe, symptomatic aortic stenosis, high surgical risk and tricuspid anatomy were enrolled in the study and… View more

Intervention
Sex Differences in Stroke Following Transcatheter Aortic Valve Replacement and the Role of Embolic Protection Devices in Women
Author(s): Mirvat Alasnag , Giulia Masiero , Chiara de Biase , et al Added: 4 days ago

CV Disease in Special Populations

Intervention
Transcatheter Heart Valves with Labelling for Aortic Regurgitation
Author(s): Pier Pasquale Leone , Azeem Latib Added: 1 month ago

Intervention

Vascular Disease and Surgery
NY Valves 25: TAVR in 2025: How Can We Do Better?
Author(s): Ole De Backer Added: 4 months ago
New York Valves 2025 - Prof Ole De Backer (Rigshospitalet, Copenhagen, DK) joins us to discuss the current landscape of transcatheter aortic valve replacement (TAVR) in 2025. Prof De Backer highlights the recent trends in current TAVR research and shares his anticipations and hopes for the future of the procedure.Interview Questions:1. What does the TAVR landscape look like in 2025, and how has… View more

Intervention
NY Valves 25: Lifetime Management in TAVR Patients
Author(s): Tanush Gupta Added: 4 months ago
New York Valves 25 - Dr Tanush Gupta (UVM Medical Center, Burlington, VT, US) joins us to discuss key conversations around lifetime management for transcatheter aortic valve replacement (TAVR) patients. He discusses key data from the NOTION trial and how this has influenced his practice, as well emerging technologies such as AI simulation models and new valves.Interview Questions:How has FDA… View more

Intervention
Embolic Protection and Stroke Prevention in TAVR
Author(s): Sunny Goel Added: 4 months ago
New York Valves 2025 - Dr Sunny Goel (Mount Sinai Hospital, New York, US) joins us to discuss the current devices and strategies that are used for embolic protection and stroke prevention in transcatheter aortic valve replacement (TAVR). Dr Goel highlights the lack of strong guidelines in the field and shares findings from recent studies investigating embolic protection devices.Interview… View more

Intervention
Aortic Valve Calcium, Aortic Stenosis and TAVI
Author(s): James Krzowski , Jonathan Weir-McCall , Luigia D’Errico , et al Added: 6 months ago

Imaging & Diagnostics

Intervention
EuroPCR 25: The TRINITY Trial
Author(s): Thomas Modine Added: 5 months ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement… View more

Heart Failure

Intervention
NY Valves 25: The Tri-QOL Study
Author(s): Added: 4 months ago
New York Valves 25 - Quantitative findings from Tri-QOL showed a strong correlation between tricuspid regurgitation (TR) reduction and KCCQ improvement after transcatheter tricuspid valve intervention (TTVI).Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, Kansas City, US) discusses findings from a quantitative analysis from the Tri-QOL study which aimed to assess the optimal result… View more

Intervention
Transcatheter Aortic Valve Implantation Indications and Patient Selection
Author(s): Jonathan Curio , Henning Guthoff , Stephan Nienaber , et al Added: 5 months ago

Vascular Disease and Surgery